ClinicalCodes.org

An online clinical codes repository to improve validity and reproducibility of medical database research

Research article:

Protocol for an observational cohort using routinely collected data from the POpulation Level Analysis and Reporting (POLAR) database in Australia to understand patterns of care for people presenting to general practice with musculoskeletal condition

Reference:

Haas R, Busija L, Gorelik A, O'Connor D, Pearce C, Mazza D, Buchbinder R.(2020) Protocol for an observational cohort using routinely collected data from the POpulation Level Analysis and Reporting (POLAR) database in Australia to understand patterns of care for people presenting to general practice with musculoskeletal condition. , doi:

Link to article
Abstract
Introduction General practice is a key component of the Australian health care system. Outcome Health’s POpulation Level Analysis and Reporting (POLAR) data space system uses de-identified electronic health records to enable data analysis at the general practice level in Australia. Previous studies using routinely collected health data for research purposes have not consistently reported the codes and algorithms used to describe the population, exposures or interventions, and outcomes in sufficient detail to allow replication. The aim of this study is to describe the methods used to classify, identify and merge eligible records from the POLAR data space system into a customised database so as to examine patterns of care for people presenting to general practice in Victoria, Australia. In doing so, this study will provide a framework for other researchers using routinely collected health data for research purposes. Methods and analysis This is a retrospective, observational cohort study. Patient-related data will be obtained through electronic health records from general practices across three primary health networks in South Eastern Victoria. Study participants will include people diagnosed with low back (aged 18 years and over), or shoulder, knee or neck conditions (aged 45 years and over) from 2014 to 2018 who were receiving care from a general practitioner (GP). Eligible records were identified deductively using coding conducted by Outcome Health and where necessary we coded data inductively. Data quality checks will be conducted and data files with eligible records will be merged to select the study cohort and create customised databases for analyses. The numbers, timing and characteristics of patients, GPs, consultations, prescriptions for pain relief, referrals to other health providers and requests for imaging tests will be examined throughout the study duration.
Author for correspondence
Romi Haas
Email for correspondence
romi.haas@monash.edu

Code list: res174: Strong single opioid medications

20 codes in list

Code Coding system Description Entity type List name
N01A ATC Fentanyl drug res174: Strong single opioid medications
N01A ATC Fentanyl citrate drug res174: Strong single opioid medications
N02A ATC Oxycodone hydrochloride, Naloxone hydrochloride drug res174: Strong single opioid medications
N02A ATC Oxycodone pectinate drug res174: Strong single opioid medications
N02A ATC Oxycodone hydrochloride drug res174: Strong single opioid medications
N02A ATC Oxycodone, Naloxone drug res174: Strong single opioid medications
N02A ATC Oxycodone drug res174: Strong single opioid medications
N02A ATC Morphine tartrate drug res174: Strong single opioid medications
N02A ATC Morphine sulfate pentahydrate drug res174: Strong single opioid medications
N02A ATC Morphine sulfate Bp drug res174: Strong single opioid medications
N02A ATC Tapentadol hydrochloride drug res174: Strong single opioid medications
N02A ATC Morphine hydrochloride trihydrate drug res174: Strong single opioid medications
N02A ATC Morphine hydrochloride drug res174: Strong single opioid medications
N02A ATC Morphine drug res174: Strong single opioid medications
N02A ATC Hydromorphone hydrochloride drug res174: Strong single opioid medications
N02A ATC Hydromorphone drug res174: Strong single opioid medications
N02A ATC Fentanyl citrate drug res174: Strong single opioid medications
N02A ATC Fentanyl drug res174: Strong single opioid medications
N02A ATC Morphine sulfate drug res174: Strong single opioid medications
N02A ATC Tapentadol drug res174: Strong single opioid medications

0 comments have been posted.

Please log in to leave a comment.